To explore this possibility, we generated a series of FOXA1 knockout (FOXA1-KO) sublines through CRISPR-Cas9 mediated gene editing of UM-UC-1 bladder cancer cells. The gene discussed is FOXA1; the disease is urinary bladder carcinoma.